| Product Code: ETC13167405 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Pharmacogenetic Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Pharmacogenetic Testing Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Africa Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.8 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.10 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.11 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.12 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Africa Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Pharmacogenetic Testing Market Trends |
6 Africa Pharmacogenetic Testing Market, 2021 - 2031 |
6.1 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.1.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Array-Based Tests, 2021 - 2031 |
6.1.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Single Gene Tests, 2021 - 2031 |
6.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C19, 2021 - 2031 |
6.2.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By CYP2D6, 2021 - 2031 |
6.2.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By CYP2C9 and VKORC1, 2021 - 2031 |
6.2.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By CYP1A2, 2021 - 2031 |
6.2.6 Africa Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*1502, 2021 - 2031 |
6.2.7 Africa Pharmacogenetic Testing Market, Revenues & Volume, By HLA-B*5701, 2021 - 2031 |
6.2.8 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.3.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Nutraceuticals, 2021 - 2031 |
6.3.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Recreational Drugs, 2021 - 2031 |
6.3.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Herbal Supplements, 2021 - 2031 |
6.3.6 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Vitamins, 2021 - 2031 |
6.3.7 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Over-the-Counter Medications, 2021 - 2031 |
6.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.4.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Saliva, 2021 - 2031 |
6.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.5.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Gastroenterology, 2021 - 2031 |
6.5.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Anesthesiology, 2021 - 2031 |
6.5.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Genomics, 2021 - 2031 |
6.5.6 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.5.7 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Immunology & Hypersensitivity, 2021 - 2031 |
6.5.8 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Dermatology, 2021 - 2031 |
6.5.9 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Clinical Practice, 2021 - 2031 |
6.6.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Development, 2021 - 2031 |
6.6.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Regulation, 2021 - 2031 |
6.7 Africa Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.7.3 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.7.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Centres and Academic Institutes, 2021 - 2031 |
6.7.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Pharmacogenetic Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
7.3.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.3.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Gene Type, 2021 - 2031 |
7.4 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.5.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Sample, 2021 - 2031 |
7.6 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.7 Africa Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.8 Africa Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.1 South Africa Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.2 Egypt Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.3 Nigeria Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.8.4 Rest of Africa Pharmacogenetic Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Africa Pharmacogenetic Testing Market Key Performance Indicators |
9 Africa Pharmacogenetic Testing Market - Export/Import By Countries Assessment |
10 Africa Pharmacogenetic Testing Market - Opportunity Assessment |
10.1 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
10.4 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.5 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
10.6 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.7 Africa Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.8 Africa Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Africa Pharmacogenetic Testing Market - Competitive Landscape |
11.1 Africa Pharmacogenetic Testing Market Revenue Share, By Companies, 2022 |
11.2 Africa Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here